Market Overview - US stock market opened slightly lower, with the Dow Jones down 0.03%, S&P 500 down 0.02%, and Nasdaq down 0.13% [1] - The Philadelphia Semiconductor Index fell by 0.62%, while Nvidia saw a slight increase of 0.34% [3] Company Highlights - Novo Nordisk's GLP-1 drug, semaglutide oral version, received FDA approval, leading to a significant stock increase of 9.5%. This drug will be available in the US starting January next year and is the first oral GLP-1 weight loss medication approved globally [3] - Chinese concept stocks faced pressure, with notable declines in companies like Xpeng Motors down over 3.7%, Miniso, NIO, and others down over 2% [3] Cryptocurrency Market - Multiple cryptocurrencies experienced significant declines, with Bitcoin dropping below $87,000 and over 90,000 traders liquidated in the past 24 hours [10][11] Economic Data - The US Commerce Department reported a 4.3% annualized growth in GDP for Q3, driven by increases in exports and consumer spending, although investment and imports declined [13]
美股、中概股下挫，小鹏跌超3%，蔚来、理想跌超2%，黄金原油短线跳水
21世纪经济报道·2025-12-23 15:29